Immunotherapy with iPSC-derived dendritic cells brings a new perspective to an old debate: autologous versus allogeneic? (2019)
Attributed to:
University of Oxford Confidence in Concept Scheme – Round 4
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18609/cgti.2019.062
Publication URI: http://dx.doi.org/10.18609/cgti.2019.062
Type: Journal Article/Review
Parent Publication: Cell and Gene Therapy Insights
Issue: 5